Utilization Of Evidence-Based Therapy For The Secondary Prevention Of Coronary Artery Disease: Predictors And Impact Of Pharmacist-Initiated Interventions

Over the past decades, secondary prevention has played a more and more important role in coronary artery disease management. Among the medications for long-term secondary prevention, antiplatelets, β-blockers, angiotensin-converting enzyme inhibitors (ACEIs), and statins were proven to be high...

Full description

Bibliographic Details
Main Author: Kassab, Yaman Walid
Format: Thesis
Language:English
Published: 2013
Subjects:
Online Access:http://eprints.usm.my/45262/
http://eprints.usm.my/45262/1/Yaman%20Walid%20Kassab24.pdf
_version_ 1848880280779096064
author Kassab, Yaman Walid
author_facet Kassab, Yaman Walid
author_sort Kassab, Yaman Walid
building USM Institutional Repository
collection Online Access
description Over the past decades, secondary prevention has played a more and more important role in coronary artery disease management. Among the medications for long-term secondary prevention, antiplatelets, β-blockers, angiotensin-converting enzyme inhibitors (ACEIs), and statins were proven to be highly effective in reducing morbidity and mortality in coronary patients. Malaysian guidelines emphasize the continuous use of these evidence-based medications (EBMs) for long-term treatment after an acute coronary event. Despite the guideline recommendations, studies have reported an underuse of these EBMs in ACS patients. The main objectives of the current study were to: (1) quantify the prescription of EBMs at discharge following an acute coronary event and ongoing use in ambulatory care, (2) evaluate the impact of pharmacist-initiated interventions on improving the prescribing trend of secondary preventive therapies upon discharge, (3) evaluate patients’ adherence to EBMs at an average of two years after discharge, and (4) investigate the relationship between patients’ non-adherence and various predictors. This study adopted an interventional comparative methodology with three phases: pre-intervention, intervention, and follow-up phases. In the pre-intervention phase, a retrospective audit was conducted and a random sample of medical records pertaining to ACS patients admitted to Hospital Pulau Pinang during the period from January 2008 to January 2010 was chosen as the control group.
first_indexed 2025-11-15T18:00:37Z
format Thesis
id usm-45262
institution Universiti Sains Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T18:00:37Z
publishDate 2013
recordtype eprints
repository_type Digital Repository
spelling usm-452622019-08-22T08:35:21Z http://eprints.usm.my/45262/ Utilization Of Evidence-Based Therapy For The Secondary Prevention Of Coronary Artery Disease: Predictors And Impact Of Pharmacist-Initiated Interventions Kassab, Yaman Walid RS1-441 Pharmacy and materia medica Over the past decades, secondary prevention has played a more and more important role in coronary artery disease management. Among the medications for long-term secondary prevention, antiplatelets, β-blockers, angiotensin-converting enzyme inhibitors (ACEIs), and statins were proven to be highly effective in reducing morbidity and mortality in coronary patients. Malaysian guidelines emphasize the continuous use of these evidence-based medications (EBMs) for long-term treatment after an acute coronary event. Despite the guideline recommendations, studies have reported an underuse of these EBMs in ACS patients. The main objectives of the current study were to: (1) quantify the prescription of EBMs at discharge following an acute coronary event and ongoing use in ambulatory care, (2) evaluate the impact of pharmacist-initiated interventions on improving the prescribing trend of secondary preventive therapies upon discharge, (3) evaluate patients’ adherence to EBMs at an average of two years after discharge, and (4) investigate the relationship between patients’ non-adherence and various predictors. This study adopted an interventional comparative methodology with three phases: pre-intervention, intervention, and follow-up phases. In the pre-intervention phase, a retrospective audit was conducted and a random sample of medical records pertaining to ACS patients admitted to Hospital Pulau Pinang during the period from January 2008 to January 2010 was chosen as the control group. 2013-07 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/45262/1/Yaman%20Walid%20Kassab24.pdf Kassab, Yaman Walid (2013) Utilization Of Evidence-Based Therapy For The Secondary Prevention Of Coronary Artery Disease: Predictors And Impact Of Pharmacist-Initiated Interventions. PhD thesis, Universiti Sains Malaysia.
spellingShingle RS1-441 Pharmacy and materia medica
Kassab, Yaman Walid
Utilization Of Evidence-Based Therapy For The Secondary Prevention Of Coronary Artery Disease: Predictors And Impact Of Pharmacist-Initiated Interventions
title Utilization Of Evidence-Based Therapy For The Secondary Prevention Of Coronary Artery Disease: Predictors And Impact Of Pharmacist-Initiated Interventions
title_full Utilization Of Evidence-Based Therapy For The Secondary Prevention Of Coronary Artery Disease: Predictors And Impact Of Pharmacist-Initiated Interventions
title_fullStr Utilization Of Evidence-Based Therapy For The Secondary Prevention Of Coronary Artery Disease: Predictors And Impact Of Pharmacist-Initiated Interventions
title_full_unstemmed Utilization Of Evidence-Based Therapy For The Secondary Prevention Of Coronary Artery Disease: Predictors And Impact Of Pharmacist-Initiated Interventions
title_short Utilization Of Evidence-Based Therapy For The Secondary Prevention Of Coronary Artery Disease: Predictors And Impact Of Pharmacist-Initiated Interventions
title_sort utilization of evidence-based therapy for the secondary prevention of coronary artery disease: predictors and impact of pharmacist-initiated interventions
topic RS1-441 Pharmacy and materia medica
url http://eprints.usm.my/45262/
http://eprints.usm.my/45262/1/Yaman%20Walid%20Kassab24.pdf